BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37482954)

  • 1. Bifidobacterium animalis subspecies lactis HN019 can reduce the sequelae of experimental periodontitis in rats modulating intestinal parameters, expression of lipogenic genes, and levels of hepatic steatosis.
    Moreira ALG; Silva GA; Silva PHF; Salvador SL; Vicente RM; Ferreira GC; Tanus-Santos JE; Mayer MPA; Ishikawa KH; de Souza SLS; Furlaneto FAC; Messora MR
    J Periodontal Res; 2023 Oct; 58(5):1006-1019. PubMed ID: 37482954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the probiotic Bifidobacterium animalis subsp. lactis on the non-surgical treatment of periodontitis. A histomorphometric, microtomographic and immunohistochemical study in rats.
    Ricoldi MST; Furlaneto FAC; Oliveira LFF; Teixeira GC; Pischiotini JP; Moreira ALG; Ervolino E; de Oliveira MN; Bogsan CSB; Salvador SL; Messora MR
    PLoS One; 2017; 12(6):e0179946. PubMed ID: 28662142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of probiotics in rats with experimental metabolic syndrome and periodontitis: An investigation of the intestine-adipose tissue axis.
    Moreira ALG; Silva PHF; Salvador SL; Ishikawa KH; Ferreira GC; Tanus-Santos JE; Mayer MPA; de Souza SLS; Furlaneto FAC; Messora MR
    J Periodontol; 2023 Nov; 94(11):1363-1375. PubMed ID: 37057371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of
    Cardoso RS; Messora MR; Silva PHF; Oliveira LF; Leite-Panissi C; Salvador S; Casarin R; Novaes AB; Palioto DB; Furlaneto FAC
    Benef Microbes; 2020 Feb; 11(1):33-46. PubMed ID: 32066256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits of Bifidobacterium animalis subsp. lactis Probiotic in Experimental Periodontitis.
    Oliveira LF; Salvador SL; Silva PH; Furlaneto FA; Figueiredo L; Casarin R; Ervolino E; Palioto DB; Souza SL; Taba M; Novaes AB; Messora MR
    J Periodontol; 2017 Feb; 88(2):197-208. PubMed ID: 27660886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Bifidobacterium animalis subsp. lactis HN019 probiotic in the prevention of periodontitis associated with immunosuppression.
    Maia LP; de Almeida Silva Levi YL; Henrique Félix Silva P; Carla Wons L; Pizzo Pitelli L; Goulart de Castro J; da Silva Dólens E; Gregorio D; Gouveia Straioto F; Dos Santos Santinoni C; Casarin R; Ervolino E; Aparecida Chaves Furlaneto F; Reis Messora M
    J Periodontol; 2023 Mar; 94(3):389-404. PubMed ID: 36245273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotic consumption can modify the resilience of periodontal tissues in rats under experimental periodontitis.
    de Oliveira LFF; Silva PHF; Salvador SL; Ervolino E; Casarin R; Figueiredo L; Ricoldi MT; de Souza SLS; Furlaneto F; Messora MR
    J Periodontol; 2023 Feb; 94(2):217-229. PubMed ID: 35690993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison Between Different Delivery Vehicles for the Probiotic Bifidobacterium animalis subsp. lactis HN019 on Experimental Periodontitis in Rats.
    Oliveira LFF; da Silva GA; Silva PHF; Moreira ALG; Salvador SL; da Cruz AG; Messora MR; Furlaneto FAC
    Probiotics Antimicrob Proteins; 2022 Apr; 14(2):313-325. PubMed ID: 35260963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of probiotics can reduce the severity of experimental periodontitis in rats with metabolic syndrome: An immunoenzymatic and microtomographic study.
    Silva GA; Moreira ALG; Silva PHF; Salvador SL; Casarin RCV; Vicente RM; Ferreira GC; Tanus-Santos JE; Furlaneto FAC; Messora MR
    J Periodontol; 2022 Feb; 93(2):e1-e12. PubMed ID: 34374081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bifidobacterium animalis subsp lactis HN019 presents antimicrobial potential against periodontopathogens and modulates the immunological response of oral mucosa in periodontitis patients.
    Invernici MM; Furlaneto FAC; Salvador SL; Ouwehand AC; Salminen S; Mantziari A; Vinderola G; Ervolino E; Santana SI; Silva PHF; Messora MR
    PLoS One; 2020; 15(9):e0238425. PubMed ID: 32960889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotic Lactobacillus rhamnosus EM1107 prevents hyperglycemia, alveolar bone loss, and inflammation in a rat model of diabetes and periodontitis.
    Silva DNA; Cruz NTS; Martins AA; Silva RCM; Almeida HC; Costa HES; Santos KMO; Vieira BR; Sousa FB; Junior FS; Júnior RFA; Guerra GCB; Pirih FQ; Araújo AA; Martins ARLA
    J Periodontol; 2023 Mar; 94(3):376-388. PubMed ID: 36322996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotic therapy reduces periodontal tissue destruction and improves the intestinal morphology in rats with ligature-induced periodontitis.
    Messora MR; Oliveira LF; Foureaux RC; Taba M; Zangerônimo MG; Furlaneto FA; Pereira LJ
    J Periodontol; 2013 Dec; 84(12):1818-26. PubMed ID: 23327675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of systemic administration of Bifidobacterium animalis subsp. lactis HN019 on apical periodontitis.
    Araujo LDC; Segato RAB; Reis TPC; Salvador SLS; Furlaneto FAC; Messora MR; Nelson-Filho P; Almeida LKY; Lucisano MP; Silva CMPC; Silva LABD
    Braz Oral Res; 2023; 37():e115. PubMed ID: 37970935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics enhance alveolar bone microarchitecture, intestinal morphology and estradiol levels in osteoporotic animals.
    Lucateli RL; Silva PHF; Salvador SL; Ervolino E; Furlaneto FAC; Marciano MA; Antunes TBM; Del Arco MCG; Tardelli MDC; de Sousa LG; Messora MR
    J Periodontal Res; 2024 May; ():. PubMed ID: 38699835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial.
    Ibarra A; Latreille-Barbier M; Donazzolo Y; Pelletier X; Ouwehand AC
    Gut Microbes; 2018; 9(3):236-251. PubMed ID: 29227175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two probiotics in follow-on formula:
    Dekker J; Quilter M; Qian H
    Benef Microbes; 2022 Oct; 13(4):341-354. PubMed ID: 36004715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral administration of Bifidobacterium animalis subsp. lactis HN019 on the treatment of plaque-induced generalized gingivitis.
    de Almeida Silva Levi YL; Ribeiro MC; Silva PHF; Silva GA; de Souza Salvador SL; de Souza SLS; Casarin R; Júnior ABN; Júnior MT; Palioto DB; Honório HM; Messora MR; Furlaneto FAC
    Clin Oral Investig; 2023 Jan; 27(1):387-398. PubMed ID: 36305963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Bifidobacterium probiotic on the treatment of chronic periodontitis: A randomized clinical trial.
    Invernici MM; Salvador SL; Silva PHF; Soares MSM; Casarin R; Palioto DB; Souza SLS; Taba M; Novaes AB; Furlaneto FAC; Messora MR
    J Clin Periodontol; 2018 Oct; 45(10):1198-1210. PubMed ID: 30076613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the Probiotic
    Araujo LDC; Furlaneto FAC; da Silva LAB; Kapila YL
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of probiotic therapy on metabolic and inflammatory parameters of rats with ligature-induced periodontitis associated with restraint stress.
    Foureaux Rde C; Messora MR; de Oliveira LF; Napimoga MH; Pereira AN; Ferreira MS; Pereira LJ
    J Periodontol; 2014 Jul; 85(7):975-83. PubMed ID: 24171503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.